Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | IMP7068 |
Synonyms | |
Therapy Description |
IMP7068 is a Wee1 inhibitor, with potential antitumor activity (J. Clin. Oncol. 40, no. 16_suppl (June 01, 2022) e15052-e15052). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IMP7068 | IMP 7068|IMP-7068 | WEE1 Inhibitor 6 | IMP7068 is a Wee1 inhibitor, with potential antitumor activity (J. Clin. Oncol. 40, no. 16_suppl (June 01, 2022) e15052-e15052). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04768868 | Phase I | IMP7068 | The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors (WEE1) | Recruiting | USA | 2 |